Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biontech Se ADR
(NQ:
BNTX
)
111.77
-2.70 (-2.36%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biontech Se ADR
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
64
65
Next >
BioNTech Whale Trades Spotted
June 17, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on BioNTech. Looking at options history for BioNTech (NASDAQ:BNTX) we detected 14 strange trades.
Via
Benzinga
Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Nod For Kids As Young As Six Months
June 17, 2022
Via
Benzinga
Pfizer, Moderna Snag FDA OK For Covid Shots In Children At 6 Months Old
June 17, 2022
The decision expands Covid shots out to the last group to become eligible.
Via
Investor's Business Daily
Pfizer-BioNTech COVID-19 Vaccine Receives FDA Emergency Use Authorization for Children 6 Months through 4 Years of Age
June 17, 2022
From
Pfizer Inc.
Via
Business Wire
BioNTech Whale Trades For June 10
June 10, 2022
A whale with a lot of money to spend has taken a noticeably bearish stance on BioNTech. Looking at options history for BioNTech (NASDAQ:BNTX) we detected 10 strange trades.
Via
Benzinga
Short Volatility Alert: BioNTech SE
June 06, 2022
On Friday, shares of BioNTech SE (NASDAQ: BNTX) experienced volatile short activity. After the activity, the stock price went down -0.42% to $157.70. The overall sentiment...
Via
Benzinga
Bavarian Nordic Launches COVID-19 Booster Study To Compare Against Pfizer/BioNTech Shot
June 16, 2022
Via
Benzinga
The Daily Biotech Pulse: Roche's Alzheimer's Drug Fails, Advisors Back Pfizer, Moderna Shots For Youngest Kids, Valneva Settles COVID-19 Pact With UK
June 16, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
FDA Committee Backs Pfizer, Moderna COVID-19 Vaccines For Toddlers, Youngest Children
June 16, 2022
The FDA's Vaccines and Related Biological Products Advisory Committee voted i
Via
Benzinga
As Omicron Surges, FDA Mulls Pfizer, Moderna Covid Shots For Babies
June 15, 2022
Pfizer studied a three-dose regimen. Moderna looked at two doses.
Via
Investor's Business Daily
The Daily Biotech Pulse: FDA Committee Backs Moderna Shot For 5-17 Years, 180 Life Sciences Stock Plunges, Pfizer's Posts Disappointing Paxlovid Data
June 15, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Wednesday, June 15
June 15, 2022
Reuters Warner Bros Discovery To Undergo Major Global Ad Sales Team Restructuring
Via
Benzinga
FDA Committee Backs Moderna's COVID-19 Shot For Kids, Adolescents: Report
June 15, 2022
Moderna Inc's (NASDAQ: MRNA) COVID-19 vaccine received unanimous backing from the FDA's committee of independent immunization experts for children ages 6 through 17.
Via
Benzinga
EU Urges Pfizer To Further Delay COVID-19 Vaccine Deliveries: Reuters
June 14, 2022
Via
Benzinga
Moderna's COVID-19 Shot Likely Related To Higher Heart Inflammation Risk Than Pfizer's: Reuters
June 14, 2022
Via
Benzinga
IBD/TIPP Poll: There's Bad News For Novavax's Covid Vaccine
June 14, 2022
Here's why its protein-based shot could struggle in the U.S.
Via
Investor's Business Daily
Moderna's Pediatric Covid Shot Is On Deck At The FDA: Here's What To Know
June 14, 2022
The FDA's vaccine experts will later vote on whether to recommend the shot.
Via
Investor's Business Daily
FDA Backs Pediatric Covid Shots; Here's Why Pfizer, Moderna Shares Crumbled
June 13, 2022
The FDA says Covid shots for children under the age of 5 are safe and effective.
Via
Investor's Business Daily
5 Biotech Stocks To Watch During The Week Of June 13
June 13, 2022
Biotech stocks continued to be under pressure in the past week amid broader market weakness, precipitated by economic worries. Company-specific developments also triggered downward moves. Here's a...
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Monday, June 13
June 13, 2022
CNBC JPMorgan Remains Bullish On Alibaba And Other Chinese Stocks - Here’s Why
Via
Benzinga
Moderna's COVID-19 Vaccine Shows Safety, Effectiveness For Children Under 17 Years
June 13, 2022
Via
Benzinga
Pfizer/BioNTech's Three-Dose COVID-19 Vaccine Safe, Effective In Younger Kids
June 13, 2022
According to the FDA briefing document, Pfizer Inc (NYSE: PFE) -BioNTech's SE (NASDAQ:
Via
Benzinga
Sanofi-GSK's Next-Gen COVID-19 Booster Shows Potential Against Variants Of Concern
June 13, 2022
Via
Benzinga
Morning Brief: Top Financial Stories Dominating on Thursday, June 9
June 09, 2022
Reuters Blackstone Closes In Crown Bid After Australia Approvals: Reuters
Via
Benzinga
US Schedules Covid-19 Vaccines For Children Below Five Years
June 09, 2022
Via
Benzinga
HC Wainwright Says Non-mRNA COVID-19 Option Underappreciated
June 08, 2022
HC Wainwright says safety concerns were noted for Novavax Inc's (NASDAQ: NVAX) COVID-19 vaccine, but the strength of data showed that benefit outweighs risks.
Via
Benzinga
What's Next For Novavax Stock As COVID Vaccine Clears Key Hurdle In US
June 08, 2022
After last week's scare stirred by the release of the Food And Drug Administration's briefing documents, Novavax (NASDAQ: NVAX) can now heave a sigh of relief.
Via
Benzinga
COVID-19 Vaccine Patent Waiver Expected Soon, Says WTO Head: Reuters
June 08, 2022
Via
Benzinga
Pfizer To Boost Production Of Oral COVID-19 Pill With $120M Michigan Investment
June 07, 2022
Pfizer, Inc. (NYSE: PFE) is upping its commitment to manufacture its oral COVID-19 pill Paxlovid in the United States.
Via
Benzinga
Early Data Shows BioNTech's Personalized Therapy Safe In Pancreatic Cancer Patients
June 06, 2022
Via
Benzinga
< Previous
1
2
...
24
25
26
27
28
29
30
31
32
...
64
65
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.